Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Summit Technology Wins FDA Approval for Further Clinical Tests

Photonics Spectra
Jan 1997
Waltham, Mass.-based Summit Technology Inc. will expand clinical trials of its excimer laser system to treat farsightedness, thanks to approval from the US Food and Drug Administration. The trials will test the company's SVS Apex Plus excimer laser system with an erodible mask for correcting hyperopia of +1.0 to +4.0 D with ¾1.0 D of astigmatism. The company will use the test data to support its premarket approval application for hyperopia treatment, which it plans to submit to the FDA late this year.

Research & TechnologyTech Pulse

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to Photonics Spectra magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.